---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-22-004406"
form_type: "8-K"
ticker: "CRVS"
cik: "0001626971"
company_name: "Corvus Pharmaceuticals, Inc."
filed_at: "2022-06-17T23:59:59+00:00"
generated_at: "2026-06-25T00:53:29.575878+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Corvus shareholders elect all director nominees, ratify auditor, approve say-on-pay

## Summary
- Elected Class III directors: Ian T. Clark (20.9M for), Elisha Gould III (22.6M for), Peter Thompson (17.1M for).
- Ratified PricewaterhouseCoopers as fiscal 2022 auditor with 35.3M votes for.
- Advisory vote on executive compensation approved (22.6M for, 0.4M against).
- Shareholders selected 1-year frequency for future say-on-pay votes (22.5M for 1 year).

## SEC filing metadata
- accession: 0001171843-22-004406
- form_type: 8-K
- ticker: CRVS
- cik: 0001626971
- company_name: Corvus Pharmaceuticals, Inc.
- filed_at: 2022-06-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1626971/000117184322004406/0001171843-22-004406-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1626971/000117184322004406/f8k_061722.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-22-004406
- JSON: https://secwatch.observer/filing/0001171843-22-004406.json
- Plain text: https://secwatch.observer/filing/0001171843-22-004406.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.